# Medico Remedies (NSE: MEDICO) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/MEDICO · Pivot · prices to 22 Oct 2026

Medico Remedies (NSE: MEDICO) closed at ₹20.71 on 22 Oct 2026, down 0.43% on the day. With a market capitalisation of ₹172 Cr, it ranks 2357th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 13.1× trailing earnings, against a return on equity of 17.4% in FY26. Over the past year the share price has fallen 57.5%. Its 52-week range is ₹20.47 (29 Sep 2026) to ₹56.88 (24 Dec 2025); the last close is 63.6% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹27,369 Cr (+84.8% year on year) and net profit ₹1,017 Cr, on a consolidated basis. Promoters held 61.38% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹20.71 |
| Market cap | ₹172 Cr |
| P/E (trailing) | 13.1 |
| ROE | 17.4% (FY26) |
| ROCE | 26.2% (FY26) |
| Debt to equity | 0.25 |
| 52-week high | ₹56.88 (24 Dec 2025) |
| 52-week low | ₹20.47 (29 Sep 2026) |
| 1-year return | −57.5% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹27,369 Cr | +84.8% | ₹1,017 Cr | — | ₹69.26 |
| Q4 FY26 | ₹16,817 Cr | −2.5% | ₹1,400 Cr | +211.1% | ₹95.48 |
| Q3 FY26 | ₹15,683 Cr | +21.3% | ₹987 Cr | +9,338.0% | ₹67.26 |
| Q2 FY26 | ₹16,327 Cr | +35.1% | ₹702 Cr | — | ₹48.30 |
| Q1 FY26 | ₹14,812 Cr | −13.4% | −₹57 Cr | −116.5% | −₹2.69 |
| Q4 FY25 | ₹17,249 Cr | −2.7% | ₹450 Cr | −26.5% | ₹31.56 |
| Q3 FY25 | ₹12,925 Cr | −25.6% | ₹10 Cr | −97.1% | ₹1.40 |
| Q2 FY25 | ₹12,086 Cr | −26.9% | −₹648 Cr | −154.5% | −₹42.56 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹151 Cr | ₹10 Cr |
| FY24 | ₹145 Cr | ₹8 Cr |
| FY23 | ₹140 Cr | ₹7 Cr |
| FY22 | ₹121 Cr | ₹5 Cr |
| FY21 | ₹122 Cr | ₹3 Cr |
| FY20 | ₹89 Cr | ₹2 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 61.38%
- Foreign institutions: 0.08%
- Non-institutions: 38.54%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Accretion Nutra](https://app.pivotnow.in/stock/ANL) | — | ₹184 Cr | — | — |
| [Earkart](https://app.pivotnow.in/stock/EARKART) | — | ₹182 Cr | — | — |
| [Novelix Pharma](https://app.pivotnow.in/stock/NOVELIX) | — | ₹181 Cr | — | — |
| [Bal Pharma](https://app.pivotnow.in/stock/BALPHARMA) | ₹109.58 | ₹174 Cr | 27.7 | — |
| [Vaidya Sane Ayu](https://app.pivotnow.in/stock/MADHAVBAUG) | ₹161.10 | ₹169 Cr | — | — |
| [Take Solutions](https://app.pivotnow.in/stock/TAKE) | ₹11.23 | ₹166 Cr | 38.7 | — |

## Questions and answers

### What is the share price of Medico Remedies today?

Medico Remedies (NSE: MEDICO) last closed at ₹20.71 on 22 Oct 2026. Its 52-week high is ₹56.88 and its 52-week low is ₹20.47.

### What is the market cap of Medico Remedies?

Medico Remedies' market capitalisation is ₹172 Cr (₹172 Cr) at the 22 Oct 2026 close, ranking 2357th among the NSE companies Pivot tracks.

### What is the P/E ratio of Medico Remedies?

Medico Remedies trades at a trailing P/E of 13.1.

### What is the ROE and ROCE of Medico Remedies?

Return on equity was 17.4% in FY26 and return on capital employed was 26.2% in FY26 (standalone figures).

### Is Medico Remedies a debt-free company?

No. Medico Remedies' debt-to-equity ratio was 0.25 in FY26, with total debt of ₹0 Cr.

### What were Medico Remedies' latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Medico Remedies reported revenue of ₹27,369 Cr, +84.8% year on year, and net profit of ₹1,017 Cr.

### How has Medico Remedies stock performed over the last year?

Medico Remedies' share price has fallen 57.5% over the past year, −46.1% over three months and −39.3% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Medico Remedies?

As of 30 Jun 2026: promoters 61.38%, foreign institutions 0.08%, non-institutions 38.54%.

### Who are Medico Remedies' competitors?

The listed Pharma & Healthcare companies closest to Medico Remedies by market cap are Accretion Nutra, Earkart, Novelix Pharma, Bal Pharma, Vaidya Sane Ayu and Take Solutions.

### Is Medico Remedies a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Medico Remedies' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MEDICO against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.